Revolution Medicines, Inc. Other intangible assets—net remained flat by 0.0% to $55.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $56.40M to $55.80M. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows relatively stable performance with a -1.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $60.41M | $60.14M | $59.88M | $59.61M | $59.34M | $58.54M | $58.81M | $58.54M | $58.27M | $58.01M | $57.74M | $57.47M | $57.21M | $56.94M | $56.67M | $56.40M | $56.14M | $55.87M | $55.80M | $55.80M |
| QoQ Change | — | -0.4% | -0.4% | -0.4% | -0.4% | -1.4% | +0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.1% | +0.0% |
| YoY Change | — | — | — | — | -1.8% | -2.7% | -1.8% | -1.8% | -1.8% | -0.9% | -1.8% | -1.8% | -1.8% | -1.8% | -1.9% | -1.9% | -1.9% | -1.9% | -1.5% | -1.1% |